nct02637284 bpc-157 results published Stable Gastric Pentadecapeptide BPC 157 as a Therapy and Safety Key: A Special Beneficial Pleiotropic Effect Controlling and Modulating Angiogenesis and the NO-System Multifunctionality and Possible Medical Application
Multifunctionality and Possible Medical Application of the BPC 157 PeptideLiterature and Patent Review A human BPC 157 trial was registered. The results were submitted. Then they disappeared from public view. In 2015, a Phase I, randomized, placebo controlled clinical trial (NCT02637284) was launched BP 157 Research In Humans Dallas Stable gastric pentadecapeptide BPC 157 in the treatment of colitis and ischemia and reperfusion in rats: New insights PMC
Pay in 4 interest-free payments of $6.68 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5


